{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T19:49:49Z","timestamp":1765828189343,"version":"3.44.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.bbr.2022.113977","type":"journal-article","created":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T21:10:28Z","timestamp":1655932228000},"page":"113977","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The role of triggering receptor expressed on myeloid cells 2 in Parkinson\u2019s disease and other neurodegenerative disorders"],"prefix":"10.1016","volume":"433","author":[{"given":"Hannah","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"B\u00e4ssler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Balta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eileen","family":"Socher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike","family":"Zunke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6645","key":"10.1016\/j.bbr.2022.113977_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"9996","key":"10.1016\/j.bbr.2022.113977_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2022.113977_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ijms22094676","article-title":"The contribution of microglia to neuroinflammation in Parkinson\u2019s disease","volume":"22","author":"Badanjak","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbr.2022.113977_bib4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: a universal immune sensor of neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.bbr.2022.113977_bib5","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/nn.2923","article-title":"Heterogeneity of CNS myeloid cells and their roles in neurodegeneration","volume":"14","author":"Prinz","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.bbr.2022.113977_bib6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/nn1997","article-title":"Microglia: active sensor and versatile effector cells in the normal and pathologic brain","volume":"10","author":"Hanisch","year":"2007","journal-title":"Nat. Neurosci."},{"issue":"7808","key":"10.1016\/j.bbr.2022.113977_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-2157-4","article-title":"Construction of a human cell landscape at single-cell level","volume":"581","author":"Han","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbr.2022.113977_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","article-title":"TREM2 variants in Alzheimer\u2019s disease","volume":"368","author":"Guerreiro","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bbr.2022.113977_bib9","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1212\/01.WNL.0000160304.00003.CA","article-title":"The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2","volume":"64","author":"Kl\u00fcnemann","year":"2005","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.bbr.2022.113977_bib10","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1212\/WNL.56.11.1552","article-title":"CNS manifestations of Nasu-Hakola disease: a frontal dementia with bone cysts","volume":"56","author":"Paloneva","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.bbr.2022.113977_bib11","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/1521-4141(200103)31:3<783::AID-IMMU783>3.0.CO;2-U","article-title":"Cloning and characterization of a novel mouse myeloid DAP12-associated receptor family","volume":"31","author":"Daws","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"49","key":"10.1016\/j.bbr.2022.113977_bib12","doi-asserted-by":"crossref","first-page":"32934","DOI":"10.1074\/jbc.273.49.32934","article-title":"DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase","volume":"273","author":"McVicar","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bbr.2022.113977_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1083\/jcb.200808080","article-title":"TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria","volume":"184","author":"N\u2019Diaye","year":"2009","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.bbr.2022.113977_bib14","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1084\/jem.20141732","article-title":"TREM-2 promotes macrophage survival and lung disease after respiratory viral infection","volume":"212","author":"Wu","year":"2015","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.bbr.2022.113977_bib15","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.neurobiolaging.2013.05.001","article-title":"Insights into TREM2 biology by network analysis of human brain gene expression data","volume":"34","author":"Forabosco","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"10.1016\/j.bbr.2022.113977_bib16","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1523\/JNEUROSCI.2459-16.2017","article-title":"TREM2 promotes microglial survival by activating Wnt\/\u03b2-catenin pathway","volume":"37","author":"Zheng","year":"2017","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.bbr.2022.113977_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.20142322","article-title":"TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer\u2019s disease mouse models","volume":"212","author":"Jay","year":"2015","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.bbr.2022.113977_bib18","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1084\/jem.194.8.1111","article-title":"A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells","volume":"194","author":"Bouchon","year":"2001","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.bbr.2022.113977_bib19","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","article-title":"The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway","volume":"181","author":"Deczkowska","year":"2020","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bbr.2022.113977_bib20","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.celrep.2018.07.094","article-title":"Human induced pluripotent stem cell-derived microglia-like cells harboring TREM2 missense mutations show specific deficits in phagocytosis","volume":"24","author":"Garcia-Reitboeck","year":"2018","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib21","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1471-4159.2009.06042.x","article-title":"A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia","volume":"109","author":"Hsieh","year":"2009","journal-title":"J. Neurochem"},{"issue":"7","key":"10.1016\/j.bbr.2022.113977_bib22","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer\u2019s disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbr.2022.113977_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13024-018-0296-y","article-title":"Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model","volume":"13","author":"Wang","year":"2018","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbrc.2018.03.226","article-title":"TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson\u2019s disease","volume":"499","author":"Zhang","year":"2018","journal-title":"Biochem Biophys. Res Commun."},{"issue":"5","key":"10.1016\/j.bbr.2022.113977_bib25","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2020.09.029","article-title":"Emerging microglia biology defines novel therapeutic approaches for Alzheimer\u2019s disease","volume":"108","author":"Lewcock","year":"2020","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.bbr.2022.113977_bib26","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1186\/1471-2164-11-642","article-title":"Genome-wide promoter analysis of histone modifications in human monocyte-derived antigen presenting cells","volume":"11","author":"Tserel","year":"2010","journal-title":"BMC Genom."},{"issue":"11","key":"10.1016\/j.bbr.2022.113977_bib27","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/nn.4126","article-title":"CD33 modulates TREM2: convergence of Alzheimer loci","volume":"18","author":"Chan","year":"2015","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.bbr.2022.113977_bib28","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.4049\/jimmunol.0901171","article-title":"DAP12 is required for macrophage recruitment to the lung in response to cigarette smoke and chemotaxis toward CCL2","volume":"184","author":"Koth","year":"2010","journal-title":"J. Immunol."},{"issue":"48","key":"10.1016\/j.bbr.2022.113977_bib29","doi-asserted-by":"crossref","first-page":"19531","DOI":"10.1073\/pnas.1306873110","article-title":"TREM2 governs Kupffer cell activation and explains belr1 genetic resistance to malaria liver stage infection","volume":"110","author":"Gon\u00e7alves","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib30","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1084\/jem.20041611","article-title":"Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2","volume":"201","author":"Takahashi","year":"2005","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.bbr.2022.113977_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10571-011-9769-z","article-title":"Gene expression profile of THP-1 monocytes following knockdown of DAP12, a causative gene for Nasu-Hakola disease","volume":"32","author":"Satoh","year":"2012","journal-title":"Cell Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.bbr.2022.113977_bib32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13024-017-0197-5","article-title":"TREM2 in neurodegenerative diseases","volume":"12","author":"Jay","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.bbr.2022.113977_bib33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s11064-008-9657-1","article-title":"Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease","volume":"34","author":"Thrash","year":"2009","journal-title":"Neurochem Res"},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib34","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.bbrc.2018.03.226","article-title":"TREM2 modulates microglia phenotypes in the neuroinflammation of Parkinson\u2019s disease","volume":"499","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.bbr.2022.113977_bib35","doi-asserted-by":"crossref","first-page":"12164","DOI":"10.1096\/fj.201900992R","article-title":"TREM2 deficiency aggravates \u03b1-synuclein-induced neurodegeneration and neuroinflammation in Parkinson\u2019s disease models","volume":"33","author":"Guo","year":"2019","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.bbr.2022.113977_bib36","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/glia.23664","article-title":"TREM2 is required for microglial instruction of astrocytic synaptic engulfment in neurodevelopment","volume":"67","author":"Jay","year":"2019","journal-title":"Glia"},{"key":"10.1016\/j.bbr.2022.113977_bib37","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.neurobiolaging.2017.01.015","article-title":"A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature","volume":"53","author":"Dardiotis","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbr.2022.113977_bib38","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3389\/fneur.2019.01252","article-title":"Neurodegenerative disease-associated variants in TREM2 destabilize the apical ligand-binding region of the immunoglobulin domain","volume":"10","author":"Dean","year":"2019","journal-title":"Front Neurol."},{"issue":"6","key":"10.1016\/j.bbr.2022.113977_bib39","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nri1106","article-title":"TREMs in the immune system and beyond","volume":"3","author":"Colonna","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bbr.2022.113977_bib40","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coi.2009.01.009","article-title":"TREM and TREM-like receptors in inflammation and disease","volume":"21","author":"Ford","year":"2009","journal-title":"Curr. Opin. Immunol."},{"issue":"12","key":"10.1016\/j.bbr.2022.113977_bib41","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ni1411","article-title":"The TREM receptor family and signal integration","volume":"7","author":"Klesney-Tait","year":"2006","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib42","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.4049\/jimmunol.177.4.2051","article-title":"Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12","volume":"177","author":"Hamerman","year":"2006","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.bbr.2022.113977_bib43","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1073\/pnas.0900463106","article-title":"Signal adaptor DAP10 associates with MDL-1 and triggers osteoclastogenesis in cooperation with DAP12","volume":"106","author":"Inui","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.bbr.2022.113977_bib44","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ni1204","article-title":"Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12","volume":"6","author":"Hamerman","year":"2005","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.bbr.2022.113977_bib45","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/eji.201141679","article-title":"TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells","volume":"42","author":"Ito","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.bbr.2022.113977_bib46","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jmb.2017.04.004","article-title":"TREM2-ligand interactions in health and disease","volume":"429","author":"Kober","year":"2017","journal-title":"J. Mol. Biol."},{"issue":"2","key":"10.1016\/j.bbr.2022.113977_bib47","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.bbr.2022.113977_bib48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJMe1213157","article-title":"Variant TREM2 as risk factor for Alzheimer\u2019s disease","volume":"368","author":"Neumann","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"122","key":"10.1016\/j.bbr.2022.113977_bib49","doi-asserted-by":"crossref","first-page":"ra38","DOI":"10.1126\/scisignal.2000500","article-title":"TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1","volume":"3","author":"Peng","year":"2010","journal-title":"Sci. Signal"},{"issue":"7","key":"10.1016\/j.bbr.2022.113977_bib50","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/ni.1744","article-title":"Macrophage colony-stimulating factor induces the proliferation and survival of macrophages via a pathway involving DAP12 and beta-catenin","volume":"10","author":"Otero","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbr.2022.113977_bib51","first-page":"15","article-title":"Triggering receptor expressed on myeloid cells 2 protects dopaminergic neurons by promoting autophagy in the inflammatory pathogenesis of Parkinson\u2019s disease","author":"Huang","year":"2021","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib52","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jalz.2016.07.004","article-title":"Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation","volume":"13","author":"Song","year":"2017","journal-title":"Alzheimers Dement"},{"issue":"6","key":"10.1016\/j.bbr.2022.113977_bib53","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.4049\/jimmunol.177.6.3520","article-title":"Cutting edge: TREM-2 attenuates macrophage activation","volume":"177","author":"Turnbull","year":"2006","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bbr.2022.113977_bib54","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.tcb.2014.12.009","article-title":"Mechanisms of inflammasome activation: recent advances and novel insights","volume":"25","author":"Vanaja","year":"2015","journal-title":"Trends Cell Biol."},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib55","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cbin.10975","article-title":"TREM2 inhibits inflammatory responses in mouse microglia by suppressing the PI3K\/NF-\u03baB signaling","volume":"43","author":"Li","year":"2019","journal-title":"Cell Biol. Int"},{"issue":"34","key":"10.1016\/j.bbr.2022.113977_bib56","doi-asserted-by":"crossref","first-page":"9587","DOI":"10.1073\/pnas.1610099113","article-title":"Caspase-1 causes truncation and aggregation of the Parkinson\u2019s disease-associated protein \u03b1-synuclein","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.bbr.2022.113977_bib57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00001756-199902250-00035","article-title":"Transgenic mice expressing a dominant negative mutant interleukin-1beta converting enzyme show resistance to MPTP neurotoxicity","volume":"10","author":"Klevenyi","year":"1999","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/j.bbr.2022.113977_bib58","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1096\/fj.201902183R","article-title":"Meprin \u03b2 cleaves TREM2 and controls its phagocytic activity on macrophages","volume":"34","author":"Berner","year":"2020","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.bbr.2022.113977_bib59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5114\/fn.2019.85929","article-title":"Risk factors for Alzheimer\u2019s disease","volume":"57","author":"AA","year":"2019","journal-title":"Folia Neuropathol."},{"issue":"24","key":"10.1016\/j.bbr.2022.113977_bib60","doi-asserted-by":"crossref","first-page":"12821","DOI":"10.1074\/jbc.M115.708297","article-title":"Presenilin 1 and presenilin 2 target \u03b3-secretase complexes to distinct cellular compartments","volume":"291","author":"Meckler","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbr.2022.113977_bib61","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/brain\/awaa021","article-title":"Soluble TREM2 is elevated in Parkinson\u2019s disease subgroups with increased CSF tau","volume":"143","author":"Wilson","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.bbr.2022.113977_bib62","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/s41467-019-09118-9","article-title":"Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer\u2019s disease model","volume":"10","author":"Zhong","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbr.2022.113977_bib63","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neurobiolaging.2021.02.024","article-title":"CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementia","volume":"103","author":"van der Ende","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"46","key":"10.1016\/j.bbr.2022.113977_bib64","doi-asserted-by":"crossref","first-page":"33027","DOI":"10.1074\/jbc.M113.517540","article-title":"Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase-dependent intramembranous cleavage","volume":"288","author":"Wunderlich","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"243","key":"10.1016\/j.bbr.2022.113977_bib65","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.bbr.2022.113977_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257372","article-title":"Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease","volume":"16","author":"Bartl","year":"2021","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bbr.2022.113977_bib67","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1523\/JNEUROSCI.2620-14.2015","article-title":"Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke","volume":"35","author":"Kawabori","year":"2015","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040124","article-title":"TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis","volume":"4","author":"Takahashi","year":"2007","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.bbr.2022.113977_bib69","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ajpath.2011.04.013","article-title":"Toll-like receptor 4 promotes \u03b1-synuclein clearance and survival of nigral dopaminergic neurons","volume":"179","author":"Stefanova","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.bbr.2022.113977_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004167","article-title":"The triggering receptor expressed on myeloid cells 2 inhibits complement component 1q effector mechanisms and exerts detrimental effects during pneumococcal pneumonia","volume":"10","author":"Sharif","year":"2014","journal-title":"PLOS Pathog."},{"issue":"5","key":"10.1016\/j.bbr.2022.113977_bib71","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2018.01.031","article-title":"TREM2 is a receptor for \u03b2-amyloid that mediates microglial function","volume":"97","author":"Zhao","year":"2018","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.bbr.2022.113977_bib72","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.15252\/embr.201743922","article-title":"TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury","volume":"18","author":"Mazaheri","year":"2017","journal-title":"EMBO Rep."},{"issue":"13","key":"10.1016\/j.bbr.2022.113977_bib73","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1038\/npp.2014.164","article-title":"Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer\u2019s disease","volume":"39","author":"Jiang","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2022.113977_bib74","doi-asserted-by":"crossref","first-page":"11118","DOI":"10.1038\/s41598-017-11634-x","article-title":"TREM2 promotes A\u03b2 phagocytosis by upregulating C\/EBP\u03b1-dependent CD36 expression in microglia","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.bbr.2022.113977_bib75","doi-asserted-by":"crossref","first-page":"992","DOI":"10.15252\/emmm.201606370","article-title":"TREM2 deficiency reduces the efficacy of immunotherapeutic amyloid clearance","volume":"8","author":"Xiang","year":"2016","journal-title":"EMBO Mol. Med"},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib76","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","article-title":"TREM2 maintains microglial metabolic fitness in Alzheimer\u2019s disease","volume":"170","author":"Ulland","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.bbr.2022.113977_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633796","article-title":"Triggering receptor expressed on myeloid cells-2 (TREM2) interacts with colony-stimulating factor 1 receptor (CSF1R) but is not necessary for CSF1\/CSF1R-mediated microglial survival","volume":"12","author":"Cheng","year":"2021","journal-title":"Front Immunol."},{"issue":"11","key":"10.1016\/j.bbr.2022.113977_bib78","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2 \u2014 a key player in microglial biology and Alzheimer disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.bbr.2022.113977_bib79","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.4049\/jimmunol.1102836","article-title":"TREM2 and \u03b2-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis","volume":"188","author":"Otero","year":"2012","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bbr.2022.113977_bib80","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","article-title":"The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases","volume":"47","author":"Krasemann","year":"2017","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bbr.2022.113977_bib81","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5582\/irdr.2017.01088","article-title":"Alzheimer\u2019s disease pathology in Nasu-Hakola disease brains","volume":"7","author":"Satoh","year":"2018","journal-title":"Intractable Rare Dis. Res"},{"key":"10.1016\/j.bbr.2022.113977_bib82","first-page":"1","article-title":"Neuropsychiatric and genetic aspects of a new hereditary disease characterized by progressive dementia and lipomembranous polycystic osteodysplasia","volume":"232","author":"Hakola","year":"1972","journal-title":"Acta Psychiatr. Scand. Suppl."},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib83","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10048-015-0451-3","article-title":"Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease","volume":"16","author":"Sasaki","year":"2015","journal-title":"Neurogenetics"},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib84","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1440-1789.2010.01174.x","article-title":"Immunohistochemical characterization of microglia in Nasu-Hakola disease brains","volume":"31","author":"Satoh","year":"2011","journal-title":"Neuropathology"},{"issue":"8","key":"10.1016\/j.bbr.2022.113977_bib85","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1474-4422(18)30232-1","article-title":"The role of TREM2 in Alzheimer\u2019s disease and other neurodegenerative disorders","volume":"17","author":"Carmona","year":"2018","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.bbr.2022.113977_bib86","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/342259","article-title":"Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype","volume":"71","author":"Paloneva","year":"2002","journal-title":"Am. J. Hum. Genet"},{"issue":"12","key":"10.1016\/j.bbr.2022.113977_bib87","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.neurobiolaging.2013.06.005","article-title":"A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family","volume":"34","author":"Guerreiro","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"11","key":"10.1016\/j.bbr.2022.113977_bib88","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/0004867417707821","article-title":"A case of TREM2 mutation presenting with features of progressive non-fluent aphasia and without bone involvement","volume":"51","author":"Chee","year":"2017","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbr.2022.113977_bib89","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jamaneurol.2013.579","article-title":"Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement","volume":"70","author":"Guerreiro","year":"2013","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.bbr.2022.113977_bib90","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","article-title":"Variant of TREM2 associated with the risk of Alzheimer\u2019s disease","volume":"368","author":"Jonsson","year":"2013","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.bbr.2022.113977_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092648","article-title":"Evidence of trem2 variant associated with triple risk of Alzheimer's disease","volume":"9","author":"Abduljaleel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbr.2022.113977_bib92","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-122311","article-title":"TREM2 R47H variant as a risk factor for early-onset Alzheimer\u2019s disease","volume":"35","author":"Pottier","year":"2013","journal-title":"J. Alzheimer\u2019S. Dis."},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib93","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.neurobiolaging.2013.10.075","article-title":"Triggering receptor expressed on myeloid cells 2 variant is rare in late-onset Alzheimer\u2019s disease in Han Chinese individuals","volume":"35","author":"Yu","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib94","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1159\/000430842","article-title":"Association study of the TREM2 gene and identification of a novel variant in exon 2 in Iranian patients with late-onset Alzheimer\u2019s Disease","volume":"24","author":"Mehrjoo","year":"2015","journal-title":"Med Princ. Pr."},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib95","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3233\/JAD-140225","article-title":"Lack of genetic association between TREM2 and late-onset Alzheimer\u2019s disease in a Japanese population","volume":"41","author":"Miyashita","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.bbr.2022.113977_bib96","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.neurobiolaging.2014.03.007","article-title":"Exome array study did not identify novel variants in Alzheimer\u2019s disease","volume":"35","author":"Chung","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.bbr.2022.113977_bib97","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1179\/1743132814Y.0000000376","article-title":"Association study of TREM2 polymorphism rs75932628 with late-onset Alzheimer\u2019s disease in Chinese Han population","volume":"36","author":"Ma","year":"2014","journal-title":"Neurol. Res"},{"issue":"9","key":"10.1016\/j.bbr.2022.113977_bib98","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/ng.3916","article-title":"Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease","volume":"49","author":"Sims","year":"2017","journal-title":"Nat. Genet"},{"issue":"4","key":"10.1016\/j.bbr.2022.113977_bib99","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3892\/etm.2021.9778","article-title":"The most prevalent rare coding variants of TREM2 conferring risk of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"21","author":"Li","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"16","key":"10.1016\/j.bbr.2022.113977_bib100","first-page":"1567","article-title":"TREM2 and neurodegenerative disease","volume":"369","author":"Benitez","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbr.2022.113977_bib101","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1326-8-19","article-title":"TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson\u2019s disease","volume":"8","author":"Rayaprolu","year":"2013","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bbr.2022.113977_bib102","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.parkreldis.2015.11.026","article-title":"TREM2 rare variant p.R47H is not associated with Parkinson\u2019s disease","volume":"23","author":"Mengel","year":"2016","journal-title":"Park. Relat. Disord."},{"issue":"12","key":"10.1016\/j.bbr.2022.113977_bib103","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jalz.2014.12.009","article-title":"The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease","volume":"11","author":"Lill","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"7","key":"10.1016\/j.bbr.2022.113977_bib104","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1007\/s12035-015-9416-7","article-title":"Convergent Genetic and Expression Datasets Highlight TREM2 in Parkinson\u2019s Disease Susceptibility","volume":"53","author":"Liu","year":"2016","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.bbr.2022.113977_bib105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/00207454.2020.1750388","article-title":"Assessment of TREM2 rs75932628 variant\u2019s association with Parkinson\u2019s disease in a Greek population and Meta-analysis of current data","volume":"131","author":"Dardiotis","year":"2021","journal-title":"Int J. Neurosci."},{"issue":"1","key":"10.1016\/j.bbr.2022.113977_bib106","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson\u2019s disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res Mol. Brain Res"},{"key":"10.1016\/j.bbr.2022.113977_bib107","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2017.01.010","article-title":"Early upregulation of 18-kDa translocator protein in response to acute neurodegenerative damage in TREM2-deficient mice","volume":"53","author":"Belloli","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbr.2022.113977_bib108","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.expneurol.2018.01.016","article-title":"TREM2 overexpression attenuates neuroinflammation and protects dopaminergic neurons in experimental models of Parkinson\u2019s disease","volume":"302","author":"Ren","year":"2018","journal-title":"Exp. Neurol."},{"issue":"11","key":"10.1016\/j.bbr.2022.113977_bib109","doi-asserted-by":"crossref","first-page":"12164","DOI":"10.1096\/fj.201900992R","article-title":"TREM2 deficiency aggravates \u03b1-synuclein-induced neurodegeneration and neuroinflammation in Parkinson\u2019s disease models","volume":"33","author":"Guo","year":"2019","journal-title":"Faseb J."},{"issue":"19","key":"10.1016\/j.bbr.2022.113977_bib110","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1093\/hmg\/ddaa209","article-title":"Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions","volume":"29","author":"Liu","year":"2020","journal-title":"Hum. Mol. Genet"},{"issue":"2","key":"10.1016\/j.bbr.2022.113977_bib111","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbr.2022.113977_bib112","unstructured":"Kluge A., Bunk J., Schaeffer E., et al. 2021."}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432822002455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432822002455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:34:21Z","timestamp":1759066461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432822002455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":112,"alternative-id":["S0166432822002455"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2022.113977","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of triggering receptor expressed on myeloid cells 2 in Parkinson\u2019s disease and other neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2022.113977","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113977"}}